Serum vascular endothelial growth factor is elevated in cystic fibrosis and decreases with treatment of acute pulmonary exacerbation.
C M
CM
Kähler
C
C
Prior
E
E
Gunsilius
D000208:Acute Disease; D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D015415:Biomarkers / Q000032:analysis; D003550:Cystic Fibrosis / Q000097:blood* / Q000150:complications; D016228:Endothelial Growth Factors / Q000097:blood*; D006801:Humans; D008222:Lymphokines / Q000097:blood* / Q000187:drug effects*; D018410:Pneumonia, Bacterial / Q000097:blood* / Q000150:complications / Q000188:drug therapy; D011379:Prognosis; D011552:Pseudomonas Infections / Q000097:blood* / Q000150:complications / Q000188:drug therapy; D012680:Sensitivity and Specificity; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors
D000900:Anti-Bacterial Agents; D015415:Biomarkers; D016228:Endothelial Growth Factors; D008222:Lymphokines; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors